WallStreetZenWallStreetZen

NASDAQ: SGMT
Sagimet Biosciences Inc Stock Ownership - Who owns Sagimet Biosciences?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Sagimet Biosciences Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
George KembleExecutive Chairman2024-07-2323,625$3.17
$74.82kSell
George KembleExecutive Chairman2024-07-1914,062$3.10
$43.61kSell
Eduardo Bruno MartinsChief Medical Officer2024-07-198,357$3.10
$25.91kSell
Elizabeth RozekGeneral Counsel and CCO2024-07-1910,914$3.10
$33.83kSell

1 of 1

SGMT insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when SGMT insiders and whales buy or sell their stock.

SGMT Shareholders

What type of owners hold Sagimet Biosciences Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Patrick J. Kerins9.36%3,013,414$28.81MInsider
Forest Baskett9.35%3,011,575$28.79MInsider
Scott D. Sandell9.34%3,007,272$28.75MInsider
Nea Partners 13 Limited Partnership9.32%3,000,275$28.68MInsider
New Enterprise Associates 13 LP9.32%3,000,275$28.68MInsider
Beth C. Seidenberg6.31%2,031,118$19.42MInsider
Kpcb Pbd Associates LLC5.90%1,899,475$18.16MInsider
Point72 Asset Management LP5.45%1,755,143$16.78MInstitution
Jinzi Jason Wu5.14%1,654,701$15.82MInsider
Blue Owl Capital Holdings LP4.13%1,328,351$12.70MInstitution

1 of 3

SGMT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
SGMT38.69%61.31%Net Selling
ADCT55.30%43.42%Net BuyingNet Selling
OLMA71.66%28.34%Net Selling
HRTX51.09%48.91%
IVA5.08%0.00%
View Top Biotech Stocks

Sagimet Biosciences Stock Ownership FAQ

Who owns Sagimet Biosciences?

Sagimet Biosciences (NASDAQ: SGMT) is owned by 42.79% institutional shareholders, 67.82% Sagimet Biosciences insiders, and 0.00% retail investors. Patrick J. Kerins is the largest individual Sagimet Biosciences shareholder, owning 3.01M shares representing 9.36% of the company. Patrick J. Kerins's Sagimet Biosciences shares are currently valued at $28.78M.

If you're new to stock investing, here's how to buy Sagimet Biosciences stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.